“Cardiovascular disease is preventable in many cases, and early identification of risk is essential, especially for people at high risk,” ACC Chief Medical Officer Richard Kovacs, MD, said in a statement. “Through this program we’re transforming cardiovascular care and improving heart health for all by ensuring clinicians are informed of the latest screening recommendations and that patients have access to the highest quality care.”
“The current reality is that not enough patients are getting screened for elevated LDL–this is especially alarming for those who have established ASCVD,” added Paul Burton, MD, PhD, senior vice president and chief medical officer at Amgen. “We see healthcare providers as a critical part of the solution but recognize that a shift of this scale requires assistance. We are proud to have joined forces with the ACC and Esperion on this collaborative effort to increase doctor-directed screening and, ultimately, helping to improve cardiovascular care and patient outcomes.”